Again, the upregulation of macrophage-derived Siglec-10 at a substantial amount was determined by FACS in the aspect of breast and ovarian cancer cells which elicits a strong affinity of CD24 to interact with Siglec-10 receptor. This evidence concerns the gene CD24 and ovarian carcinoma.